Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Lowering certain hormone levels improves treatment for hair loss in young men.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

A 13-year-old boy with Cushing syndrome has high cortisol levels from a pituitary gland issue and underdeveloped sexual characteristics.

Salivary testosterone is a better measure for hirsutism than serum testosterone.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Testosterone affects skin by increasing oil production and influences hair growth.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Prostate cancer risk is not linked to blood testosterone levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Human skin releases different steroids, with some coming from sebaceous glands and others from sweat glands.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Low prolactin in young women may increase heart and metabolism risks.